Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Ocugen (2) Acquired (1)
autologous culture chondrocytes (Carticel) (3 trials)
brimonidine (alphagan) (3 trials)
imidazoquinoline (2 trials)
cellulose (1 trial)
ocu400 (1 trial)
ocu410 (2 trials)
ocu200 (1 trial)
Dry Eye Syndromes (Phase 3)
Eye Diseases (Phase 3)
Graft vs Host Disease (Phase 3)
Keratoconjunctivitis Sicca (Phase 3)
Trials (12 total)
Trial APIs (7 total)